Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced ...

Currently, Olvi-Vec is being evaluated in the OnPrime/GOG-3076 Phase 3 registrational trial in the United States, with the primary endpoint of progression free survival (Clinicaltrials.gov ...

The primary objectives of this trial are to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of systemically administered Olvi-Vec in the target population. The data ...

Early trial results show combining the oncolytic virus olvi-vec with chemotherapy led to disease control and tolerable safety in extensive-stage small cell lung cancer. Preliminary results from the ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

An extensive experimental program to measure the spin structure of the nucleons is carried out in Hall B with the CLAS detector at Jefferson Lab using a polarized electron beam incident on a polarized ...

Helicity-dependent incoherent pion photoproduction in the reaction \vec \gamma \vec d\to \pi NN is studied in the framework of the diagrammatic approach. Contributions to the reaction amplitude from ...